No Picture
News

Therapeutic Solutions International Launches Campbell Neurosciences Inc as First Suicide Focused Regenerative Psychiatry Biotechnology Company

Campbell Neurosciences to License Key Intellectual Property Assets as Clinical Trials of Campbell Score and Kaihani Score are Ongoing

OCEANSIDE, Calif., Dec. 31, 2020 /PRNewswire/ — Therapeutic Solutions International, Inc., (OTC Markets: TSOI), ann… […]

No Picture
News

Therapeutic Solutions International Launches Clinical Trial to Validate First Blood Based Predicator of Suicidal Ideation: The Campbell Score(TM)

Clinical Stage Biotech Company Aims to Develop Biology Based Means of Assessing Suicide Risk and Providing Immunotherapy Based Interventions

OCEANSIDE, Calif., Oct. 29, 2020 /PRNewswire/ — Therapeutics Solution International, Inc., (OTC Markets: TSO… […]

No Picture
News

Neurocrine Biosciences and Me2/Orchestra, in Partnership with Mental Health Advocacy Groups, Honor Mental Illness Awareness Week by Launching Monumental Moments(TM), an Online Community Platform and Charitable Initiative to Support, Inspire and Connect People During the Pandemic

– Monumental Moments Encourages People to Share How They are Caring for Their Mental Health during These Unprecedented and Challenging Times on Social Media with Hashtag #MonumentalMoments- Me2/Orchestra, World’s Only Known Classical Music Organization… […]

No Picture
News

Therapeutic Solutions International Reports Synergistic Suppression of Suicide-Associated Neuroinflammatory Pathway by QuadraMune(TM) and Minocycline

Campbell Neurosciences Division Continues its Mission of “Treating Suicide as a Biological Disease”

OCEANSIDE, Calif., Aug. 28, 2020 /PRNewswire/ — Therapeutics Solution International, Inc., (OTC Markets: TSOI), reported filing a patent on new data … […]

No Picture
News

Camino Pharma receives $920K Small Business Innovation Research (SBIR) grant from the National Institute of Mental Health

New class of drugs focuses on treating major depression

SAN DIEGO, June 30, 2020 /PRNewswire/ — Camino Pharma, LLC, a biotech company focused on finding cures for cancer and brain disorders, announced today that its co-founder and CSO, Reto Gadient,… […]

No Picture
News

Neurocrine Biosciences Announces New Data Published from the Largest Real-World Screening Study, RE-KINECT, Demonstrating that Movements Consistent with Tardive Dyskinesia Occur Frequently and Can Reduce Quality of Life in Patients with Psychiatric Disorders

— Results from Real-World Screening Study Highlight Importance of Raising Awareness of Tardive Dyskinesia During Mental Health Month — 75% of Patients with Possible Tardive Dyskinesia Affirmed Feeling Self-Conscious or Embarrassed About Involuntary … […]

No Picture
News

Denovo Biopharma Announces Breakthrough Discovery of a Novel Genetic Biomarker for DB104 (Liafensine) for Depression

– Potential First Pharmagenomic Biomarker in Neurological Diseases

SAN DIEGO, March 12, 2020 /PRNewswire/ –?Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced it has successfully discovere… […]